Hi-Vision Medical (02407): The intraocular lens implantation system obtained a medical device registration certificate in China

Zhitongcaijing · 05/09 08:41

Zhitong Finance App News, Gaoshi Healthcare (02407) announced that the “artificial lens implantation system” of Gaoshi Tailiang Medical Technology Co., Ltd. (Gaoshi Tailiang), a wholly-owned subsidiary of the Japanese company, has obtained a medical device registration certificate approved by the Guangdong Drug Administration.

According to the “Guidelines for Adult Cataract Removal Surgery in China (2023)”, cataracts are the first blinding disease in the world.

Gaoshitailiang's approved artificial lens implantation system (registration certificate number: Guangdong Instrument Note 20252160605) is mainly suitable for intraocular lens implantation surgery in small-incision cataract surgery. Compared with the artificial lens implantation system approved in 2024 (registration certificate number: Guangdong Instrument No. 20242161490), it optimizes the surgical incision to less than 1.8 mm, which can minimize corneal trauma and accelerate recovery after surgery. At the same time, the surface of the implantation head achieves ultra-low resistance to crystal injection and significant improvement in surgical efficiency through the use of chemical graft lubrication coating technology.

This product is an original design by Gaoshitailiang, and has been authorized by an invention patent. The technical feature of the invention patent is that it is possible not only to install different types of introduction heads on its main tube to implant lenses of different surgical incisions, but also to be expanded into a prefabricated implant system to adapt to all types of artificial lenses on the market for intraocular lens implantation surgery.